Literature DB >> 9039983

Refinement of the laminin alpha2 chain locus to human chromosome 6q2 in severe and mild merosin deficient congenital muscular dystrophy.

I S Naom1, M D'Alessandro, H Topaloglu, C Sewry, A Ferlini, A Helbling-Leclerc, P Guicheney, J Weissenbach, K Schwartz, K Bushby, J Philpot, V Dubowitz, F Muntoni.   

Abstract

About half of the children with classical congenital muscular dystrophy (CMD) show an absence in their skeletal muscle of laminin alpha2 chain, one of the components of the extracellular matrix protein, merosin. Linkage analysis implicated the laminin alpha2 chain gene (LAMA2) on chromosome 6q2, now confirmed by the discovery of mutations in the laminin alpha2 chain gene. We have further investigated the location of the LAMA2 locus on chromosome 6q2, using both linkage analysis in nine informative families and homozygosity mapping in 13 consanguineous families. Four of these families only had mild or moderate down regulation of laminin alpha2 chain expression and a milder phenotype; the rest had no protein or only a trace. Haplotype analysis in all the informative families, including those with partial laminin alpha2 expression, was compatible with linkage to chromosome 6q2. This observation expands the spectrum of the phenotype secondary to laminin alpha2 chain deficiency. Our results suggest that the LAMA2 locus is more centromeric than previously proposed. Recombinant events place the locus between markers D6S470 and D6S1620 in an interval of less than 3 cM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039983      PMCID: PMC1050860          DOI: 10.1136/jmg.34.2.99

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  20 in total

1.  Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy. 22-24 April 1994, The Netherlands.

Authors:  V Dubowitz; M Fardeau
Journal:  Neuromuscul Disord       Date:  1995-05       Impact factor: 4.296

2.  Occidental type cerebromuscular dystrophy: a report of eleven cases.

Authors:  H Topaloğlu; K Yalaz; Y Renda; M Cağlar; S Göğüs; G Kale; K Gücüyener; G Nurlu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

3.  An efficient salt-chloroform extraction of DNA from blood and tissues.

Authors:  R Müllenbach; P J Lagoda; C Welter
Journal:  Trends Genet       Date:  1989-12       Impact factor: 11.639

4.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

5.  22nd ENMC sponsored workshop on congenital muscular dystrophy held in Baarn, The Netherlands, 14-16 May 1993.

Authors:  V Dubowitz
Journal:  Neuromuscul Disord       Date:  1994-01       Impact factor: 4.296

6.  A new nomenclature for the laminins.

Authors:  R E Burgeson; M Chiquet; R Deutzmann; P Ekblom; J Engel; H Kleinman; G R Martin; G Meneguzzi; M Paulsson; J Sanes
Journal:  Matrix Biol       Date:  1994-04       Impact factor: 11.583

7.  Readjusting the localization of merosin (laminin alpha 2-chain) deficient congenital muscular dystrophy locus on chromosome 6q2.

Authors:  A Helbling-Leclerc; H Topaloglu; F M Tomé; C Sewry; G Gyapay; I Naom; F Muntoni; V Dubowitz; A Barois; B Estournet
Journal:  C R Acad Sci III       Date:  1995-12

8.  Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children.

Authors:  E S Lander; D Botstein
Journal:  Science       Date:  1987-06-19       Impact factor: 47.728

9.  Congenital muscular dystrophy with merosin deficiency.

Authors:  F M Tomé; T Evangelista; A Leclerc; Y Sunada; E Manole; B Estournet; A Barois; K P Campbell; M Fardeau
Journal:  C R Acad Sci III       Date:  1994-04

10.  Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues.

Authors:  R Vuolteenaho; M Nissinen; K Sainio; M Byers; R Eddy; H Hirvonen; T B Shows; H Sariola; E Engvall; K Tryggvason
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

View more
  9 in total

Review 1.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

2.  Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A.

Authors:  Jinger A Doe; Ryan D Wuebbles; Erika T Allred; Jachinta E Rooney; Margaret Elorza; Dean J Burkin
Journal:  J Cell Sci       Date:  2011-06-07       Impact factor: 5.285

3.  Impaired fetal muscle development and JAK-STAT activation mark disease onset and progression in a mouse model for merosin-deficient congenital muscular dystrophy.

Authors:  Andreia M Nunes; Ryan D Wuebbles; Apurva Sarathy; Tatiana M Fontelonga; Marianne Deries; Dean J Burkin; Sólveig Thorsteinsdóttir
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

4.  Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23.

Authors:  D N Messina; M C Speer; M A Pericak-Vance; E M McNally
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

5.  Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42.

Authors:  M Brockington; C A Sewry; R Herrmann; I Naom; A Dearlove; M Rhodes; H Topaloglu; V Dubowitz; T Voit; F Muntoni
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 6.  The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.

Authors:  K J Jones; G Morgan; H Johnston; V Tobias; R A Ouvrier; I Wilkinson; K N North
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

7.  Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.

Authors:  Jachinta E Rooney; Jolie R Knapp; Bradley L Hodges; Ryan D Wuebbles; Dean J Burkin
Journal:  Am J Pathol       Date:  2012-02-06       Impact factor: 4.307

Review 8.  The role of laminins in the organization and function of neuromuscular junctions.

Authors:  Robert S Rogers; Hiroshi Nishimune
Journal:  Matrix Biol       Date:  2016-09-07       Impact factor: 11.583

9.  Abnormalities of dystrophin, the sarcoglycans, and laminin alpha2 in the muscular dystrophies.

Authors:  K J Jones; S S Kim; K N North
Journal:  J Med Genet       Date:  1998-05       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.